A Phase I Study of HS-10386 in Participants With Advanced Solid Tumors

Clinical trial NCT05911464 · RECRUITING

Trial details

NCT number: NCT05911464
Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2023-03-02
Primary completion: 2025-10-31
Enrollment: 248

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.